Data-Driven Decision Making for New Drugs: A Collaborative Learning Experience
George P. Sillup,
Ronald K. Klimberg and
David P. McSweeney
Additional contact information
George P. Sillup: Saint Joseph’s University, USA
Ronald K. Klimberg: Saint Joseph’s University, USA
David P. McSweeney: Healthcare Data Management, Inc., USA
International Journal of Business Intelligence Research (IJBIR), 2010, vol. 1, issue 2, 42-59
Abstract:
Two courses, advanced decision-making and pharmaceutical marketing, were combined in a collaborative process to mimic how the pharmaceutical industry determines the potential of new drugs. Integrated student teams worked together to complete semester-long projects and taught each other their respective knowledge areas—marketing and statistics. Real-world data for medical and pharmacy claims payments were “cleaned” and mined by students to analyze usage and cost patterns for anti-hypertensive and anti-hypercholesterolemia drugs currently on the market. Analyses included merging the medical and pharmaceutical data records to derive individual electronic patient records, which were the basis of financial projections for the new drugs. Importantly, the single patient record is congruent with the needs of the stakeholders currently working to reform U.S. healthcare delivery.
Date: 2010
References: Add references at CitEc
Citations:
Downloads: (external link)
http://services.igi-global.com/resolvedoi/resolve. ... 4018/jbir.2010040105 (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:igg:jbir00:v:1:y:2010:i:2:p:42-59
Access Statistics for this article
International Journal of Business Intelligence Research (IJBIR) is currently edited by Ana Azevedo
More articles in International Journal of Business Intelligence Research (IJBIR) from IGI Global
Bibliographic data for series maintained by Journal Editor ().